脑脊液
τ蛋白
阿尔茨海默病
病理
痴呆
单克隆抗体
抗体
表位
退行性疾病
化学
疾病
分子生物学
内科学
生物
医学
免疫学
作者
Marc Vandermeeren,Marc Mercken,Eugeen Vanmechelen,Jan Six,A. Van de Voorde,Jean‐Jacques Martin,Patrick Cras
标识
DOI:10.1111/j.1471-4159.1993.tb09823.x
摘要
Abstract— Alzheimer's disease is a progressive degenerative dementia characterized by the abundant presence of neurofibrillary tangles in neurons. This study was designed to test whether the microtubule‐associated protein, a major component of neurofibrillary tangles, could be detected in CSF. Additionally, we investigated whether CSF levels were abnormal in Alzheimer's disease as compared with a large group of control patients. We developed a sensitive sandwich enzyme‐linked immunosorbent assay using AT120, a monoclonal antibody directed to human, as a capturing antibody. With this technique, the detection limit for was less than 5 pg/ml of CSF. Using ATS, which recognizes abnormally phosphorylated ser‐ines 199–202 in, the detection limit was below 20 pg/ml of CSF. However, with AT8, we found no immunoreactiv‐ity in CSF, suggesting that only a small fraction of CSF contains the abnormally phosphorylated AT8 epitope. Our results indicate that CSF levels are significantly increased in Alzheimer's disease. Also, CSF levels in a large group of patients with a diversity of neurological diseases showed overlap with CSF levels in Alzheimer's disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI